PAULA CANTERINO: Open Payments
NPI 1548349145 · MANASQUAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 22 payments from 9 companies in 2025. Trend: 2023 $504 · 2024 $533 · 2025 $450
Food & beverage: $405Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $156 |
| Daiichi Sankyo Inc. | 5 | $119 |
| TAIHO ONCOLOGY, INC. | 3 | $64 |
| Eisai Inc. | 1 | $19 |
| SpringWorks Therapeutics, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Invivyd Inc | 1 | $18 |
| Boston Scientific Corporation | 1 | $18 |
| PharmaEssentia USA Corporation | 1 | $18 |
Products named: Enhertu, IMBRUVICA, LONSURF, VENCLEXTA, Lenvima, OGSIVEO, EPKINLY, PEMGARDA.
Industry payments across NJ — which companies pay providers there.
